Aptevo Therapeutics
(NASDAQ) APVO
Aptevo Therapeutics Financials at a Glance
Market Cap
$5.16M
Revenue (TTM)
$0.00
Net Income (TTM)
$25.97M
EPS (TTM)
$-1779.06
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$4.33
Volume
413
Open
$4.35
Price
$4.33
Volume
413
Open
$4.35
Previous Close
$4.37
Daily Range
$4.25 - $4.42
52-Week Range
$3.80 - $486.00
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$4.33
Volume
413
Open
$4.35
Previous Close
$4.37
Daily Range
$4.25 - $4.42
52-Week Range
$3.80 - $486.00
APVO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aptevo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
36
CEO
Marvin L. White, MBA
Website
www.aptevotherapeutics.comHeadquarters
Seattle, WA 98121, US
APVO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-248%
Return on Capital
-1%
Return on Assets
-95%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-0.35%
Stock Overview
Market Cap
$5.16M
Shares Outstanding
1.18M
Volume
413
Short Interest
0.00%
Avg. Volume
65.17K
Financials (TTM)
Gross Profit
$240.00K
Operating Income
$26.31M
EBITDA
$26.07M
Operating Cash Flow
$25.59M
Capital Expenditure
$0.00
Free Cash Flow
$25.59M
Cash & ST Invst.
$21.62M
Total Debt
$4.63M
Aptevo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$81.00K
-14.1%
Gross Margin
0.00%
N/A
Market Cap
$5.16M
N/A
Market Cap/Employee
$139.57K
N/A
Employees
37
N/A
Net Income
$5.81M
+8.0%
EBITDA
$5.89M
+6.7%
Quarterly Fundamentals
Net Cash
$16.99M
+315.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.76M
-18.7%
Short Term Debt
$866.00K
N/A
Return on Assets
-95.49%
N/A
Return on Invested Capital
-1.24%
N/A
Free Cash Flow
$5.24M
+9.1%
Operating Cash Flow
$5.24M
+9.1%